China Isotope & Radiation Corporation Stock

Equities

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:22 2024-05-10 am EDT 5-day change 1st Jan Change
11 HKD -0.72% Intraday chart for China Isotope & Radiation Corporation +0.36% -17.66%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 6.15B 851M 6.65B Sales 2023 6.63B 918M 7.18B Capitalization 3.88B 538M 4.2B
Net income 2022 392M 54.26M 424M Net income 2023 371M 51.35M 401M EV / Sales 2022 0.28 x
Net cash position 2022 2.06B 286M 2.23B Net cash position 2023 1.24B 172M 1.34B EV / Sales 2023 0.4 x
P/E ratio 2022
9.65 x
P/E ratio 2023
10.5 x
Employees 3,105
Yield 2022
3.73%
Yield 2023
2.58%
Free-Float 91.21%
More Fundamentals * Assessed data
Dynamic Chart
China Isotope & Radiation Corporation Announces First Carrier-Free Lutetium-177 GMP Production Line with Annual Production Capacity of 10,000-Curie GMP-Grade Lutetium-177 CI
China Isotope & Radiation to Form JV Company MT
China Network Group Co., Ltd. Enters into the Investment and Cooperation Agreement with CNNC Hainan Nuclear Power CI
China Isotope & Radiation Corporation Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable Before 13 August 2024 CI
China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Isotope & Radiation Corporation Announces Resignation of Chen Shoulei as Non-Executive Director, Vice Chairman, Members of the Strategy Committee, the Audit and Risk Management Committee and the Legal Affairs Committee of the Board CI
China Isotope & Radiation Breath Test Kit Gets a Clinical Approval Nod MT
China Isotope & Radiation Corporation Announces Approval by the National Medical Products Administration, Shenzhen Zhonghe Headway Bio-Sci & Tech Co. Ltd CI
China Isotope & Radiation Arm Secures Safety License for Production Facility in Xinjiang MT
China Isotope & Radiation Subsidiary Secures Compliance Accreditation MT
CIRC to Buy Radiation Processing Research and Technology Firm MT
China Isotope & Radiation Gets New Direct Controlling Shareholder MT
China Isotope & Radiation Corporation Elects Zhang Junqi as an Executive Director CI
China Isotope & Radiation Corporation Announces Resignation of Wang Suohui as Director CI
China Isotope's Nuclear Energy Project Gets 'Outstanding' Rating MT
More news
1 day-0.72%
1 week+0.36%
Current month+3.77%
1 month+7.63%
3 months-1.61%
6 months-13.25%
Current year-17.66%
More quotes
1 week
10.32
Extreme 10.32
11.18
1 month
9.03
Extreme 9.03
11.18
Current year
9.03
Extreme 9.03
13.26
1 year
9.03
Extreme 9.03
19.24
3 years
9.03
Extreme 9.03
32.10
5 years
9.03
Extreme 9.03
35.40
10 years
9.03
Extreme 9.03
35.40
More quotes
Managers TitleAgeSince
Director/Board Member 54 16-04-30
Director/Board Member 53 22-07-28
Comptroller/Controller/Auditor 50 20-10-31
Members of the board TitleAgeSince
Director/Board Member 61 23-06-29
Director/Board Member 53 22-07-28
Director/Board Member 55 17-02-21
More insiders
Date Price Change Volume
24-05-10 11 -0.72% 183 000
24-05-09 11.08 +5.73% 142,800
24-05-08 10.48 -2.24% 251,000
24-05-07 10.72 -1.83% 206,000
24-05-06 10.92 -0.36% 100,200

Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT

More quotes
China Isotope & Radiation Corporation is a China-based company mainly engaged in research, development, manufacturing and sales of radiopharmaceuticals and radioactive source products. The Company operates mainly through five segments. The Pharmaceuticals segment is mainly engaged in the manufacture and sales of various radiopharmaceuticals for imaging diagnosis and treatment, urea breath test kits and testers, as well as in vitro diagnostic reagents and kits. The Radioactive Source Product segment is mainly engaged in the production and sales of various radioactive source products, and provides related technical services. The Irradiation segment mainly provides irradiation sterilization services and others. The Radiotherapy Equipment and Related Services segment is mainly engaged in the research and development of radiotherapy equipment. The Independent Medical Laboratory Services and Other Business segment mainly provides independent medical laboratory services.
More about the company

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW